Download FREE Report Sample
Download Free sampleChronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected.
Chronic Refractory Cough Treatment Market contains market size and forecasts of Chronic Refractory Cough (CRC) Treatment in Global, including the following market information:
Global Chronic Refractory Cough (CRC) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Refractory Cough (CRC) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Speech Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Refractory Cough (CRC) Treatment include Merck, Nerre Therapeutics, Bellus Health, Attenua, Respivant Sciences and Shionogi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Refractory Cough (CRC) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Refractory Cough (CRC) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Refractory Cough (CRC) Treatment Market Segment Percentages, by Type, 2021 (%)
Speech Therapy
Physiotherapy
Global Chronic Refractory Cough (CRC) Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chronic Refractory Cough (CRC) Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Chronic Refractory Cough (CRC) Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chronic Refractory Cough (CRC) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Refractory Cough (CRC) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Refractory Cough (CRC) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Nerre Therapeutics
Bellus Health
Attenua
Respivant Sciences
Shionogi
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
